DIETARY NUTRICEUTICAL TREATMENT

Brand Owner (click to sort) Address Description
ARTHROPROTEK THETA BIOMEDICAL CONSULTING AND DEVELOPMENT CO., INC. 14 Parkman St. Brookline MA 02446 Dietary nutriceutical for the treatment of human disease, namely, arthritis;ARTHROPROTECT;
FIBROPROTEK THETA BIOMEDICAL CONSULTING AND DEVELOPMENT 6804 ARECA BOULEVARD SARASOTA FL 34241 Dietary nutriceutical for the treatment of human disease, namely, fibromyalgia;FIBRO PROTEK; FIBRO PROTECT;
FIBROPROTEK Theta Biomedical Consulting and Development Co., Inc 14 Parkman St. Brookline MA 02446 Dietary nutriceutical for the treatment of human disease, namely, fibromyalgia;FIBRO PROTEK;
FIBROPROTEK Theta Biomed. Consult. Develop., Inc 14 Parkman St. Brookline MA 02446 Dietary nutriceutical for the treatment of human disease, namely, fibromyalgia;FIBRO PROTEK; FIBRO PROTECT;
FIBROPROTEK Theta Biomed. Consult. Develop. Inc 14 Parkman St. Brookline MA 02446 Dietary nutriceutical for the treatment of human disease, namely, fibromyalgia;FIBRO PROTEK;
MAXPROTEK Theta Biomedical Consulting and Development Co., Inc 357 Commercial Street, Suite 725 Boston MA 02109 Dietary nutriceutical for the treatment of human disease, namely, prostatitis;MAX PROTECT;
SUPERPROTEK THETA BIOMEDICAL CONSULTING AND DEVELOPMENT CO., INC. 14 Parkman St. Brookline MA 02446 Dietary nutriceutical for the treatment of human disease, namely, coronary artery disease;SUPER PROTECT;
ULTRAPROTEK Theta Biomedical Consulting and Development Co., Inc 14 Parkman St. Brookline MA 02446 Dietary nutriceutical for the treatment of human disease, namely, cystitis;ULTRA PROTECT;
ULTRAPROTEK Theta Biomed. Consult. Develop. Co., Inc 14 Parkman St. Brookline MA 02446 Dietary nutriceutical for the treatment of human disease, namely, cystitis;ULTRA PROTECT;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.